The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts

The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts

Background: Newborn screening for congenital adrenal hyperplasia (CAH-NBS) is not yet a worldwide consensus, in part due to inconclusive evidence regarding cost-effectiveness because the analysis requires an understanding of the short- and long-term costs of care associated with delayed diagnosis.Ob...

Full description

Bibliographic Details
Main Authors: Mirela Costa de Miranda, Luciana Bertocco de Paiva Haddad, Evelinda Trindade, Alex Cassenote, Giselle Y. Hayashi, Durval Damiani, Fernanda Cavalieri Costa, Guiomar Madureira, Berenice Bilharinho de Mendonca, Tania A. S. S. Bachega
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Pediatrics
Subjects:
cost-effectiveness
newborn screening
economic evaluation
21-hydroxilase deficiency
congenital adrenal hyperplasia
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2021.659492/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2021.659492/full

Similar Items